leisure time -WSS

leisure time

author：explore 2025-10-01 01:50:37 - browse：536

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Inaction leaves children at risk from dangerous chemotherapy drug

WSS

Future doctors need a strong humanities education

Update the Apgar Score to remove skin color

HPV vaccine, cervical cancer study delivers historic results

Future doctors need a strong humanities education

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Why depression after traumatic brain injury is distinct

focus

leisure time

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

After affirmative action ruling, medical educators look to 'holistic review'

Change Healthcare outage fallout shows need for new oversight

The cancer drug shortage isn’t new — and neither are the solutions

EPA limits use of carcinogenic gas for sterilizing medical devices

Drug repurposing or repositioning? The language matters

Steward Health Care Massachusetts hospitals face fiscal disaster

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Steward Health Care Massachusetts hospitals face fiscal disaster

knowledge

Head of FDA's diagnostics center, who led through Covid, retires

Head of FDA's diagnostics center, who led through Covid, retires

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

UCLA team creates talking throat patch for voice disorders

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Why scientists need input from humanists on sensitive research

leisure time

Wikipedia

hotspot

entertainment